Abstract
The clinically inflammatory tumors are considered to be very severe carcinomas characterized by a particularly low rate of survival at 5 years [6, 14]. In the present study, we have simultaneously determined estrogen receptors (ER) and progesterone receptors (PgR) in these tumors and compared the results with those obtained in primary operable carcinomas. The prognostic value of ER has also been studied.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bloom HJG (1950) Prognosis in carcinoma of the breast. Br J Cancer 4: 259–288
Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 have been followed 15 years. Br J Cancer 11: 359–377
Boyd JT, Doll R (1954) Gastro-intestinal cancer and the use of liquid paraffin. Br J Cancer 8: 231–237
Contesso G, Rouesse J, Petit JY, Mouriesse H (1977) Les facteurs anatomo-pathologiques du pronostic des cancers du sein. Bull Cancer 64: 525–536
Cooke J, George O, Shields R, Maynard P, Griffiths K (1979) Estrogen Receptors and prognosis in early breast cancer. Lancet 1: 995–997
Fletcher WS, Montague FO (1975) Radical irradiation of advanced breast cancer. Am J Roentgen Radium Ther Nucl Med 3: 573–584
Fletcher WS, Leung BS, Davenport CE (1978) The prognostic significance of estrogen receptors in human breast cancer. Am J Surg 135: 372–374
Furmanski P, Saunders DE, Brooks SC, Rich MA (1980) The prognostic value of estrogen receptor determinations in patients with primary breast cancer. Cancer 46: 2794–2796
Haagensen CS (1971) Inflammatory carcinoma. In: Diseases of the breast. Saunders, Philadelphia, p 580
Horwitz KB, McGuire WL, Pearson OH, Segaloff A (1975) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726–727
Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Statist Ass 53: 457–481
King RJB (1980) Analysis of estradiol and progesterone receptors in early and advanced breast tumors. Cancer 46: 2818–2821
Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognosis factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Lacour J, Hourtoule FG (1967) La place de la chirurgie dans le traitement des formes évolutives du cancer du sein. Mem Acad Chir 635–643
Martin PM, Jacquemier J, Rolland PH, Rolland AM, Toga M (1978) Correlations entre les récepteurs hormonaux stéroïdiens et l’anatomo-pathologie des tumeurs mammaires humaines. Bull Cancer 65: 383–388
May-Levin F, Guerinot F, Contesso G, Delarue JC, Bohuon C (1977) Etude des récepteurs cytosoliques estrogènes et progestogènes dans les carcinomes mammaires. Int J Cancer 19: 789–795
Maynard PV, Davies CJ, Blarney RW, Elston CW, Johnson J, Griffiths K (1978) Relationship between oestrogen-receptor content and histological grade in human primary breast tumour. Br J Cancer 38: 745–748
McCarty KS Jr, Barton TK, Fetter BF, Woodard BH, Mossier JA, Reeves W, Daly J, Wilkinson WE, McCarty K (1980) Correlation of estrogen and progesterone receptors with histological differentiation in mammary carcinoma. Cancer 46: 2851–2858
McGuire WL, Vollmer EP, Carbone PP (eds) (1975) Estrogen receptors in human breast cancer. Raven, New York
McGuire WL, Raynaud JP, Baulieu EE (eds) (1977) Progesterone receptors in normal and neoplastic tissues. Raven, New York
Millis RR (1980) Correlation of hormone receptors with pathological features in human breast cancer. Cancer 46: 2869–2871
Osborne CK, Yochmowitz MG, Knight WA, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888
Peto R, McPike, Armitage P, Breslow N, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 34: 585–612
Raynaud JP, Bouton MM, Philibert D, Delarue JC, Guerinot F, Bohuon C (1977) Progesterone and estradiol binding sites in human breast carcinoma. In: Vermeulen A (ed) Research in steroids, vol 7. Elsevier, Amsterdam, pp 281–290
Sarrazin D, Rouesse J, Arriagada R, May-Levin F, Petit JY, Contesso G (1978) Les cancers du sein en “poussée évolutive”. Rev Prat 28: 999–1009
Scarff RW, Torloni H (1968) Co 11 international histological classification of tumors no 2. WHO, Geneva, pp 204–408
Wittliff JL, Beatty BW, Savlov ED, Patterson WB, Cooper RA (1976) Estrogen receptors and hormone dependency in human breast cancer. In: St Arneault G, Baud P, Israel L (eds) Breast cancer: a multidisciplinary approach. Springer, Berlin Heidelberg New York, pp 59–77 (Recent results in cancer research, vol 57 )
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Contesso, G., May-Levin, F., Delarue, J.C., Mouriesse, H., Sancho-Garnier, H., Lemaout, M. (1984). Inflammatory Tumors of the Human Breast: Determination of Estrogen and Progesterone Receptors. In: Leclercq, G., Toma, S., Paridaens, R., Heuson, J.C. (eds) Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Recent Results in Cancer Research, vol 91. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82188-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-82188-2_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82190-5
Online ISBN: 978-3-642-82188-2
eBook Packages: Springer Book Archive